检索结果 - Weijun Fu

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Successful treatment of newly diagnosed <scp>POEMS</scp> syndrome with reduced‐dose bortezomib based regimen

    Successful treatment of newly diagnosed <scp>POEMS</scp> syndrome with reduced‐dose bortezomib based regimen 由 Haiyan He, Weijun Fu, Juan Du, Hua Jiang, Jian Hou

    出版 2017
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  2. 2
    The Role of Mitochondria in Pyroptosis

    The Role of Mitochondria in Pyroptosis 由 Qian Li, Nengxian Shi, Chen Cai, Mingming Zhang, Jing He, Ying Tan, Weijun Fu

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    SIRT1-mediated HMGB1 deacetylation suppresses sepsis-associated acute kidney injury

    SIRT1-mediated HMGB1 deacetylation suppresses sepsis-associated acute kidney injury 由 Siwei Wei, Youguang Gao, Xingui Dai, Weijun Fu, Shumin Cai, Haihong Fang, Zhenhua Zeng, Zhongqing Chen

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Single‐cell RNA‐seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma

    Single‐cell RNA‐seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma 由 Haiyan He, Zifeng Li, Jing Lü, Wanting Qiang, Sihan Jiang, Yaochen Xu, Weijun Fu, Xiaowen Zhai, Lin Zhou, Maoxiang Qian, Juan Du

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Melatonin and its analogues for the prevention of postoperative delirium: A systematic review and meta‐analysis

    Melatonin and its analogues for the prevention of postoperative delirium: A systematic review and meta‐analysis 由 Yunyang Han, Jie Wu, Zaisheng Qin, Weijun Fu, Bing-Cheng Zhao, Xue Li, Wenyan Wang, Tong Sha, Maomao Sun, Jiaxin Li, Zhenhua Zeng, Zhongqing Chen

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma

    MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma 由 Juan Du, Shuyan Liu, Jie He, Xi Liu, Ying Qu, Wenqing Yan, Jianling Fan, Rong Li, Hao Xi, Weijun Fu, Chunyang Zhang, Jing Yang, Jian Hou

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Transfection of chimeric anti‐CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells

    Transfection of chimeric anti‐CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells 由 Hua Jiang, Wenhao Zhang, Peipei Shang, Hui Zhang, Weijun Fu, Fei Ye, Tianmei Zeng, Hejing Huang, Xueguang Zhang, Wanping Sun, Daniel Sze, Qing Yi, Jian Hou

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials

    MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials 由 Bruno Paiva, Irene Manrique, Meletios Α. Dimopoulos, Francesca Gay, Chang‐Ki Min, Sonja Zweegman, Ivan Špıčka, Raphael Teipel, María‐Victoria Mateos, Nicola Giuliani, Michèle Cavo, Christine Rojas Hopkins, Weijun Fu, Kaveri Suryanarayan, Alexander Vorog, Cong Li, Bingxia Wang, Jose Estevam, Richard Labotka, Ajeeta B. Dash

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma

    Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma 由 Jie Xu, Lijuan Chen, Shuangshuang Yang, Yan Sun, Wen Wu, Yuanfang Liu, Ji Xu, Yan Zhuang, Wu Zhang, Xiangqin Weng, Jing Wu, Yan Wang, Jin Wang, Hua Yan, Wenbin Xu, Hua Jiang, Juan Du, Xiaoyi Ding, Biao Li, Junmin Li, Weijun Fu, Jiang Zhu, Li Zhu, Chen Zhu, Xiao-Hu Fan, Jian Hou, Jianyong Li, Jian‐Qing Mi, Sai‐Juan Chen

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

    Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2) 由 Wanhong Zhao, Baiyan Wang, Lijuan Chen, Weijun Fu, Jie Xu, Jie Liu, S Jin, Yinxia Chen, Xing-Mei Cao, Yun Yang, Yilin Zhang, Fangxia Wang, Pengyu Zhang, Bo Lei, Liufang Gu, Jianli Wang, Hui Zhang, Ju Bai, Yan Xu, Han Zhu, Juan Du, Hua Jiang, Xiao-Hu Fan, Jianyong Li, Jian Hou, Chen Zhu, Wanggang Zhang, Jian‐Qing Mi, Sai‐Juan Chen, Aili He

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial

    The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial 由 Tingyu Wang, Xiuhua Sun, Lihua Qiu, Hang Su, Junning Cao, Zhiming Li, Yuqin Song, Li Zhang, Dengju Li, Huijing Wu, Wei Zhang, Junmin Li, Keshu Zhou, Hui Zhou, Yu Yang, Zhifeng Li, Hong Cen, Zhen Cai, Zhihui Zhang, Weijun Fu, Jie Jin, Fei Li, Weixin Wu, Xuekui Gu, Weiliang Zhu, Lihong Liu, Zengjun Li, Shuhua Yi, Hanying Bao, Zusheng Xu, Lugui Qiu

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: